Roy D. Baynes - Insider Trading & Ownership

Entity
Individual
Location
C/O Retrophin, Inc., 12255 El Camino Real, Suite 250, San Diego, CA
Summary
The estimated net worth of Roy D. Baynes is at least $2.6M dollars as of November 15, 2024. Roy D. Baynes is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $2.37M. Roy D. Baynes is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $209K. Roy D. Baynes is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $16.9K.
All Insider Reports
All Insider Reports

Ownership of Roy D. Baynes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTRA Natera, Inc. Director $2.37M -$5.44M -69.6% Nov 15, 2024
TVTX Travere Therapeutics, Inc. Director $209K May 8, 2024
ATRA Atara Biotherapeutics, Inc. Director $16.9K Jun 23, 2022

Insider Transactions Reported by Roy D. Baynes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.